MFN2-related neuropathies

Clinical features, molecular pathogenesis and therapeutic perspectives

Giulia Stuppia, Federica Rizzo, Giulietta Riboldi, Roberto Del Bo, Monica Nizzardo, Chiara Simone, Giacomo P. Comi, Nereo Bresolin, Stefania Corti

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Abstract Mitofusin 2 (MFN2) is a GTPase dynamin-like protein of the outer mitochondrial membrane, encoded in the nuclear genome by the MFN2 gene located on the short (p) arm of chromosome 1. MFN2 protein is involved in several intracellular pathways, but is mainly involved in a network that has an essential role in several mitochondrial functions, including fusion, axonal transport, interorganellar communication and mitophagy. Mutations in the gene encoding MFN2 are associated with Charcot-Marie-Tooth disease type 2A (CMT2A), a neurological disorder characterized by a wide clinical phenotype that involves the central and peripheral nervous system. Here, we present the clinical, genetic and neuropathological features of human diseases associated with MFN2 mutations. We also report proposed pathogenic mechanisms through which MFN2 mutations likely contribute to the development of neurodegeneration. MFN2-related disorders may occur more frequently than previously considered, and they may represent a paradigm for the study of the defective mitochondrial dynamics that seem to play a significant role in the molecular and cellular pathogenesis of common neurodegenerative diseases; thus they may also lead to the identification of related therapeutic targets.

Original languageEnglish
Article number13818
Pages (from-to)7-18
Number of pages12
JournalJournal of the Neurological Sciences
Volume356
Issue number1-2
DOIs
Publication statusPublished - Sep 15 2015

Fingerprint

Mutation
Mitochondrial Degradation
Mitochondrial Dynamics
Dynamins
Axonal Transport
Chromosomes, Human, Pair 1
GTP Phosphohydrolases
Peripheral Nervous System
Mitochondrial Membranes
Nervous System Diseases
Neurodegenerative Diseases
Genes
Proteins
Therapeutics
Central Nervous System
Communication
Genome
Phenotype
Type 2A Charcot-Marie-Tooth disease

Keywords

  • Charcot-Marie-Tooth disease type 2A
  • Clinical and genetic features
  • Mitochondrial network
  • Mitofusin 2
  • Neurodegeneration
  • Pathogenetic mechanisms

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

MFN2-related neuropathies : Clinical features, molecular pathogenesis and therapeutic perspectives. / Stuppia, Giulia; Rizzo, Federica; Riboldi, Giulietta; Del Bo, Roberto; Nizzardo, Monica; Simone, Chiara; Comi, Giacomo P.; Bresolin, Nereo; Corti, Stefania.

In: Journal of the Neurological Sciences, Vol. 356, No. 1-2, 13818, 15.09.2015, p. 7-18.

Research output: Contribution to journalArticle

@article{9795492cb4d84e1689b963adcb5c23cf,
title = "MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives",
abstract = "Abstract Mitofusin 2 (MFN2) is a GTPase dynamin-like protein of the outer mitochondrial membrane, encoded in the nuclear genome by the MFN2 gene located on the short (p) arm of chromosome 1. MFN2 protein is involved in several intracellular pathways, but is mainly involved in a network that has an essential role in several mitochondrial functions, including fusion, axonal transport, interorganellar communication and mitophagy. Mutations in the gene encoding MFN2 are associated with Charcot-Marie-Tooth disease type 2A (CMT2A), a neurological disorder characterized by a wide clinical phenotype that involves the central and peripheral nervous system. Here, we present the clinical, genetic and neuropathological features of human diseases associated with MFN2 mutations. We also report proposed pathogenic mechanisms through which MFN2 mutations likely contribute to the development of neurodegeneration. MFN2-related disorders may occur more frequently than previously considered, and they may represent a paradigm for the study of the defective mitochondrial dynamics that seem to play a significant role in the molecular and cellular pathogenesis of common neurodegenerative diseases; thus they may also lead to the identification of related therapeutic targets.",
keywords = "Charcot-Marie-Tooth disease type 2A, Clinical and genetic features, Mitochondrial network, Mitofusin 2, Neurodegeneration, Pathogenetic mechanisms",
author = "Giulia Stuppia and Federica Rizzo and Giulietta Riboldi and {Del Bo}, Roberto and Monica Nizzardo and Chiara Simone and Comi, {Giacomo P.} and Nereo Bresolin and Stefania Corti",
year = "2015",
month = "9",
day = "15",
doi = "10.1016/j.jns.2015.05.033",
language = "English",
volume = "356",
pages = "7--18",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - MFN2-related neuropathies

T2 - Clinical features, molecular pathogenesis and therapeutic perspectives

AU - Stuppia, Giulia

AU - Rizzo, Federica

AU - Riboldi, Giulietta

AU - Del Bo, Roberto

AU - Nizzardo, Monica

AU - Simone, Chiara

AU - Comi, Giacomo P.

AU - Bresolin, Nereo

AU - Corti, Stefania

PY - 2015/9/15

Y1 - 2015/9/15

N2 - Abstract Mitofusin 2 (MFN2) is a GTPase dynamin-like protein of the outer mitochondrial membrane, encoded in the nuclear genome by the MFN2 gene located on the short (p) arm of chromosome 1. MFN2 protein is involved in several intracellular pathways, but is mainly involved in a network that has an essential role in several mitochondrial functions, including fusion, axonal transport, interorganellar communication and mitophagy. Mutations in the gene encoding MFN2 are associated with Charcot-Marie-Tooth disease type 2A (CMT2A), a neurological disorder characterized by a wide clinical phenotype that involves the central and peripheral nervous system. Here, we present the clinical, genetic and neuropathological features of human diseases associated with MFN2 mutations. We also report proposed pathogenic mechanisms through which MFN2 mutations likely contribute to the development of neurodegeneration. MFN2-related disorders may occur more frequently than previously considered, and they may represent a paradigm for the study of the defective mitochondrial dynamics that seem to play a significant role in the molecular and cellular pathogenesis of common neurodegenerative diseases; thus they may also lead to the identification of related therapeutic targets.

AB - Abstract Mitofusin 2 (MFN2) is a GTPase dynamin-like protein of the outer mitochondrial membrane, encoded in the nuclear genome by the MFN2 gene located on the short (p) arm of chromosome 1. MFN2 protein is involved in several intracellular pathways, but is mainly involved in a network that has an essential role in several mitochondrial functions, including fusion, axonal transport, interorganellar communication and mitophagy. Mutations in the gene encoding MFN2 are associated with Charcot-Marie-Tooth disease type 2A (CMT2A), a neurological disorder characterized by a wide clinical phenotype that involves the central and peripheral nervous system. Here, we present the clinical, genetic and neuropathological features of human diseases associated with MFN2 mutations. We also report proposed pathogenic mechanisms through which MFN2 mutations likely contribute to the development of neurodegeneration. MFN2-related disorders may occur more frequently than previously considered, and they may represent a paradigm for the study of the defective mitochondrial dynamics that seem to play a significant role in the molecular and cellular pathogenesis of common neurodegenerative diseases; thus they may also lead to the identification of related therapeutic targets.

KW - Charcot-Marie-Tooth disease type 2A

KW - Clinical and genetic features

KW - Mitochondrial network

KW - Mitofusin 2

KW - Neurodegeneration

KW - Pathogenetic mechanisms

UR - http://www.scopus.com/inward/record.url?scp=84939262128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939262128&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2015.05.033

DO - 10.1016/j.jns.2015.05.033

M3 - Article

VL - 356

SP - 7

EP - 18

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

M1 - 13818

ER -